TrialClinical cancer research : an official journal of the American Association for Cancer Research2021

Biomarker Analysis of the Phase III NALA Study of Neratinib + Capecitabine versus Lapatinib + Capecitabine in Patients with Previously Treated Metastatic Breast Cancer.

Cristina Saura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.